title: Insulin and insulinlike growth factor receptors regulating neurite formation in cultured human neuroblastoma cells.
abstract: The functional role of brain insulin and insulinlike growth factor (IGF) receptors is being sought. Recently it has been found that these ligands are members of a newly identified family of neuritogenic polypeptides. We studied the relationship between 125I-insulin and 125I-IGF binding and their capacity to enhance neurite formation in cultured human neuroblastoma SH-SY5Y cells. The binding of 125I-insulin was temperature-dependent and heterogeneous. The Scatchard plot and dissociation rate were both consistent with the presence of two types of sites. There appeared to be about 900 high affinity sites per cell with a Kd of about 3 nM. This compared favorably with the half-maximal concentration of 4 nM for enhancement of neurite formation. The type I IGF sites were also present. Physiologic concentrations of insulin clearly enhanced neurite formation through the insulin sites, whereas physiologic concentrations of IGF-I and IGF-II enhanced through the IGF sites. Cross-occupancy of sites was observed at supraphysiologic concentrations, providing a reasonable explanation for the broad dose-response curves for these ligands. These results support the suggestion that one function of insulin and IGF receptors in neural tissues may be to modulate neurite formation.
authors.affiliation: Department of Anesthesiology, Medical College, Cornell University, New York, New York.
authors.forename: E
authors.initials: E
authors.lastname: Recio-Pinto
authors.forename: D N
authors.initials: DN
authors.lastname: Ishii
mesh_terms: D001369:Axons / Q000187:drug effects / Q000502:physiology*; D001667:Binding, Competitive; D002460:Cell Line; D006801:Humans; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology*; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D007335:Insulin-Like Growth Factor II / Q000494:pharmacology*; D007700:Kinetics; D009447:Neuroblastoma; D011972:Receptor, Insulin / Q000187:drug effects / Q000378:metabolism; D013002:Somatomedins / Q000494:pharmacology*
chemical_list: D007328:Insulin; D013002:Somatomedins; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D011972:Receptor, Insulin